ClinicalTrials.gov
ClinicalTrials.gov Menu

Interaction Between Anaesthetics and Methylene Blue

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00513032
Recruitment Status : Completed
First Posted : August 8, 2007
Last Update Posted : August 8, 2007
Sponsor:
Information provided by:
University Hospital, Geneva

Brief Summary:
We hypothesized that pre-treatment with methylene blue could potentiate the effects of general anaesthetic agents in patients undergoing parathyroidectomy

Condition or disease Intervention/treatment
Hyperparathyroidism Drug: methylene blue

  Show Detailed Description

Study Type : Observational
Actual Enrollment : 22 participants
Observational Model: Case Control
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Effects of Methylene Blue on Propofol Requirement During Anaesthesia Induction and Surgery
Study Start Date : January 2005
Actual Study Completion Date : April 2007

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anesthesia
U.S. FDA Resources

Group/Cohort Intervention/treatment
Case: methylene blue Drug: methylene blue
5mg.kg-1 methylene blue in 250 ml 5% glucose-saline, administered intravenously approximately 60 min before anaesthesia induction
Control: C Drug: methylene blue
5mg.kg-1 methylene blue in 250 ml 5% glucose-saline, administered intravenously approximately 60 min before anaesthesia induction




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients undergoing parathyroidectomy or partial thyroidectomy

Exclusion Criteria:

  • Psychiatric disorders
  • Drug abuse
  • Weight 20% more or less than ideal body weight

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00513032


Locations
Switzerland
Service d'Anesthésiologie, Hôpitaux Universitaires de Genève, Rue Micheli-du-Crest
Geneva, Switzerland, CH-1211
Sponsors and Collaborators
University Hospital, Geneva
Investigators
Principal Investigator: Marc Licker, MD University Hospital, Geneva

ClinicalTrials.gov Identifier: NCT00513032     History of Changes
Other Study ID Numbers: 02-081(02-006)
First Posted: August 8, 2007    Key Record Dates
Last Update Posted: August 8, 2007
Last Verified: August 2007

Keywords provided by University Hospital, Geneva:
propofol
anaesthesia induction
parathyroidectomy
methylene blue
General anesthesia

Additional relevant MeSH terms:
Hyperparathyroidism
Parathyroid Diseases
Endocrine System Diseases
Anesthetics
Propofol
Methylene Blue
Central Nervous System Depressants
Physiological Effects of Drugs
Hypnotics and Sedatives
Anesthetics, Intravenous
Anesthetics, General
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action